GSK Executive Discusses Vaccine R&D Investments, Challenges
Bloomberg TV: Upfront Vaccine Costs a Hurdle to Business: Slaoui
In a video report, “Moncef Slaoui, R&D and vaccines chairman at GlaxoSmithKline, discusses the financial challenges to developing vaccines, the importance of research and development to the pharmaceutical industry from the 2014 Milken Global Conference on Bloomberg Television’s ‘Market Makers'” (4/29).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.